re- e tender ( 2nd call ) for procurement of drug items ( 2021-23 ) , listed under table-a, for two years from the date of award of contract. , amiodarone inj. 50mg / ml in 3ml vial / amp , adenosine inj. u.s.p. 3 mg / ml in 2 ml. , cefoperazone + sulbactum 1.5gm inj. , dexamethasone sodium phosphate inj. i.p. 8mg. / 2ml. vial , dextrose solution i.p. 5% ( blow fill & seal process ) , fentanyl citrate inj.b.p. 50mcg / ml - 2 ml amps. , gentamycin sulphate inj.i.p.  80mg / 2ml vial , heparin sodium inj.i.p. 5000 i.u. / ml. , hydrocortisone  sodium succinate inj. i.p.  100 mg / vial , l-asperginase inj.5000 iu / vial , merbromin solution usnf ( mercurochrome solution 2% w / v ) , naloxone inj 400 mcg / ml in 1 ml amp. , nitroglycerin inj.u.s.p. 25mg / 5 ml amp. , olopatadine hydrochloride eye solution 0.1% w / v , piperacillin 4 gm + tazobactum 500 mg inj. / vial , ringer lactate solution i.p. inj. ( blow fill & seal process ) , sodium chloride inj ip 0.9% normal or isotonic saline ) na +154 mmol / l, cl-154 mmol / l ( blow fill & seal process )